The History of Controlling and Treating Infectious Diseases in Ancient China
Infectious diseases are the common enemies of mankind. In the course of historical development, they persistently threaten human health and safety. Even today, despite the developments in medical science, we cannot escape the fear and suffering caused by infectious diseases. Whether in ancient or modern times, the source of infection, route of transmission, and a susceptible population are the three key conditions for the prevalence and spread of infectious diseases. All factors closely related to these three conditions can affect the prevalence of infectious diseases. China is one of the cradles of world civilization. The ancient people accumulated a great deal of experience and lessons in the long struggle against infectious diseases. In the face of the current threat posed by widespread infectious disease, it is imperative to review and summarize ancient Chinese ideas and health policies on epidemic prevention and control to inspire contemporary efforts in the prevention and control of infectious disease. The combination of prevention-oriented epidemic prevention ideology and traditional medicine provides valuable insights, especially for impoverished and medically underserved regions.
infectious diseases / Chinese medicine / public health / historical review
[1] | Deng YT. The History of Famine Relief in China. Beijing: Commercial Press, 2017:49–50 |
[2] | Yu R, Huang AQ. Overview of epidemics and prevention in ancient China. Hunan Zhongyiyao Daxue Xuebao (Chinese), 2004,(03):19–20,23 |
[3] | Gong SS. Changes of the temporal-spatial distribution of epidemic disasters in 770 BC-AD 1911 China. Acta Geographica Sinica (Chinese), 2003,(06):870–878 |
[4] | Jiang X, Wang Y, Wang P, et al. Control infectious diseases according to law of ancient China and enlightenment to modern times. Zhonghua Jiezhichang Jibing Zazhi (Electronic Edition) (Chinese), 2020,9(02):209–212 |
[5] | Chen RS. Historical Review and Modern Enlightenment of Traditional Chinese Medicine Treatmentin Epidemic Diseases (Yi-Diseases). Zhongguo Heli Yongyao Zazhi (Chinese), 2020,17(02):8–13 |
[6] | Liu JX. The understanding of infectious disease prevention in ancient China. Zhongguo Yiyao Zhinan (Chinese), 2012,10(28):236–239 |
[7] | Tognotti E. The origins of the health defence system against contagious illness: the strategies of isolation and quarantine in Mediterranean cities from the XIV-XIX centuries. Adler Mus Bull, 2005,31(1):6–17 |
[8] | Tognotti E. Lessons from the history of quarantine, from plague to influenza A. Emerg Infect Dis, 2013,19(2):254–259 |
[9] | Confucius. The Analects of Confucius (Chinese). In: Zhang YG, editor. Wuhan: Chongwen Publishing House, 2015. |
[10] | Hu PS, Li TH. Bamboo slips and research unearthed in the Yangtze River Basin (Chinese). Wuhan: Hubei Education Press, 2004. |
[11] | Ban G. The Book of Han (Chinese). Taiyuan: Shanxi Ancient Books Press, 2004. |
[12] | Fang XL. Book of Jin (Chinese). Beijing: Zhonghua Book Company, 2000. |
[13] | Zhou G. Rites of Zhou (Chinese). In: Xu ZY, Chang PY, editor. Beijing: Zhonghua Book Company, 2014. |
[14] | Marco P. The Travels of Marco Polo. London: Henry G. Bohn, 1854. |
[15] | Lv BW. Lv’s Spring and Autumn, 2nd ed (Chinese). In: Liu YG, editor. Wuhan: Chongwen Publishing House, 2015. |
[16] | Sun SM. Valuable Prescriptions for Emergency (Chinese). Beijing: People’s Medical Publishing House, 1982. |
[17] | Li SZ. Compendium of Materia Medica (Chinese). Beijing: People’s Medical Publishing House, 2002. |
[18] | Hu ZX, Hu ZY. Wanbing Yanfang: Dingbu Jianyi Beiyanfang (Chinese). Beijing: Chinese Medicine Ancient Books Publishing House, 1991. |
[19] | Duggan AT, Perdomo MF, Piombino-Mascali D, et al. 17th Century Variola Virus Reveals the Recent History of Smallpox. Curr Biol, 2016,26(24):3407–3412 |
[20] | Cao X. Immunology in China: the past, present and future. Nat Immunol, 2008,9(4):339–342 |
[21] | Voltaire. Lettres Philosophiques (Chinese, trans. Gao DG). Shanghai: Shanghai People’s Publishing House, 2005. (Original work published 1733) |
[22] | Ren W, Liang P, Ma Y, et al. Research progress of traditional Chinese medicine against COVID-19. Biomed Pharmacother, 2021,137:111310 |
[23] | Ge H. Handbook of Prescriptions for Emergencies (Chinese). Beijing: China Press of Traditional Chinese Medicine, 2016. |
[24] | Zhang TJ, Wang YF, Liu D, et al. Historical story on natural medicinal chemistry: Artemisinin—a milestone of traditional Chinese medicine study (Chinese). Chinese Herbal Medicines, 2016,47(19):3351–3361 |
[25] | Howard J, Huang A, Li Z, et al. An evidence review of face masks against COVID-19. Proc Natl Acad Sci U S A, 2021,118(4):e2014564118 |
[26] | Maner M, LeMasters K, Lao J, et al. COVID-19 in corrections: Quarantine of incarcerated people. PLoS One, 2021,16(10):e0257842 |
[27] | Kerr GM, Crowley M, O’Reilly EJ, et al. Justifying quarantine in preventing the spread of COVID-19 in healthcare. Occup Med (Lond), 2021,71(6–7):250–254 |
[28] | Grepin KA, Aston J, Burns J. Effectiveness of international border control measures during the COVID-19 pandemic: a narrative synthesis of published systematic reviews. Philos Trans A Math Phys Eng Sci, 2023,381(2257):20230134 |
[29] | Wang LD, Guo JG, Wu XH, et al. China’s new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Trop Med Int Health, 2009,14(12):1475–1483 |
[30] | Sun LP, Wang W, Hong QB, et al. Approaches being used in the national schistosomiasis elimination programme in China: a review. Infect Dis Poverty, 2017,6(1):55 |
[31] | Zhang L, He J, Yang F, et al. Progress of schistosomiasis control in People’s Republic of China in 2022. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (Chinese), 2023,35(3):217–224 |
[32] | Yu W, Lee LA, Liu Y, et al. Vaccine-preventable disease control in the People’s Republic of China: 1949–2016. Vaccine, 2018,36(52):8131–8137 |
[33] | Liao X, Liang Z. Strategy vaccination against Hepatitis B in China. Hum Vaccin Immunother, 2015;11(6):1534–1539 |
[34] | Li R, Shen M, Ong JJ, et al. Blueprint to hepatitis B elimination in China: A modelling analysis of clinical strategies. JHEP Rep, 2023,5(10):100833 |
/
〈 | 〉 |